Centre for Human Drug Research (CHDR)

Leiden, South Holland 2333 CL

0 studies enrolling now · 2 studies all time

What they study most

Amyotrophic Lateral Sclerosis, Chronic Inducible Urticaria

Studies at this site

• Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria — Completed
• A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis — Completed